COGR Update
COGR Meeting Report - February 2011
The COGR Meeting Report from February 2011 provides a detailed overview of the key issues and developments affecting research universities in the areas of costing policies, contracts and intellectual property, and research compliance and administration. The report emphasizes significant audit activities led by the Federal Office of Inspectors General, especially in regards to administrative and cl
February 2016 Update
The February 2016 COGR Update provides an extensive overview of recent and emerging issues impacting the administration of federally funded research at U.S. universities. Key topics include transitions and compliance challenges associated with NIH's new 120-day grant closeout policy, including the complex reconciliation requirements between financial reporting systems, and evolving policies s
February 2016 Update Summary
The February 2016 Update from the Council on Governmental Relations (COGR) provides an extensive overview of key regulatory, fiscal, and policy developments impacting research institutions. Major NIH policy updates address grant closeout processes, salary cap increases, and numerous fiscal and award-related clarifications, with efforts to clarify differing requirements for contracts versus grants.
May 2013 Update
The May 2013 Update provides a comprehensive overview of recent policy developments, legislative updates, and institutional responses in the realm of government-funded research. Notably, the National Science Board is actively addressing the administrative burdens on principal investigators (PIs), with COGR urging its members to participate in the consultation process. Legislative attention centers
May 2014 Update
The May 2014 Update from COGR provides a detailed overview of recent regulatory, policy, and legislative developments affecting research institutions, including efforts to reduce administrative burdens on investigators, revisions in NIH grant policies following the Defense of Marriage Act decision, upcoming NIH requirements to account for sex differences in preclinical research, guidance on implem
